Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delayed Donor Leukocyte Infusions for AIDS-Related Lymphoma
NCT00024128Phase 2Withdrawn
- Sponsor
- AIDS Malignancy Consortium
- Start
- Aug 2001
- Primary completion
- Mar 2003
- Modality
- Cell Therapies
01
Overview
Phase 2, open-label, single-arm trial of therapeutic allogeneic lymphocytes in AIDS-related lymphoma, sponsored by AIDS Malignancy Consortium. Primary endpoints: Objective Response Rate at 1 year, Complication Rate at 1 year and 1 more. Planned start Aug 2001; status: withdrawn.
02
Drugs
therapeutic allogeneic lymphocytes
03
Conditions
AIDS-related lymphoma
Beyond the preview
Go deeper on NCT00024128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00024128.